Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04400487 · ClinicalTrials.gov registry record · Phase 4
Actigraphy Improvement With Voxelotor (ActIVe) Study
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT04400487 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 25 participants.
The verdict
NCT04400487, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a study to evaluate the effect of voxelotor on daily physical activity and sleep quality, as measured by a wrist-worn device in participants with sickle cell disease (SCD) and chronic moderate anemia.
Interventions
- DRUG Voxelotor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2022-09-13 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04400487
The ClinicalTrials.gov registry entry for NCT04400487 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Voxelotor is the first listed.
NCT04400487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04400487 about?
NCT04400487 is a clinical study titled "Actigraphy Improvement With Voxelotor (ActIVe) Study". This is a study to evaluate the effect of voxelotor on daily physical activity and sleep quality, as measured by a wrist-worn device in participants with sickle cell disease (SCD) and chronic moderate anemia.
What is the current status of trial NCT04400487?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2020-12-21. Estimated completion is 2022-09-13.
What interventions are being tested in trial NCT04400487?
The interventions under investigation include: Voxelotor (DRUG).
Who is sponsoring clinical trial NCT04400487?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.